📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Tasly Pharmaceutical Group Co Ltd
Tasly Pharmaceutical Group's GHG Emissions Data Preview
In 2024, Tasly Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Tasly Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Tasly Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Tasly Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.
Insights into Tasly Pharmaceutical Group's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofTasly Pharmaceutical Group amounted to143,697.01metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Tasly Pharmaceutical Groupincreased by 7.1%, suggesting that the company faced challenges in reducing its emissions from its core operations.ab
Tasly Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Tasly Pharmaceutical Group's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Tasly Pharmaceutical Group were 37,369.84 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year(2023), Tasly Pharmaceutical Group's Scope 1 emissions decreased by 2.76%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.ab
What are Tasly Pharmaceutical Group's Scope 2 emissions?
In 2024, Tasly Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 106,327.17 tCOâ‚‚e without specifying the calculation method.a
Has Tasly Pharmaceutical Group reduced its Scope 2 emissions over time?
Compared to the previous year(2023), Tasly Pharmaceutical Group's Scope 2 emissions(Unspecified Calculation Method) rose by 11.06% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energyab
What methodology does Tasly Pharmaceutical Group use for Scope 2 reporting?
In 2024, Tasly Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.a
Tasly Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Tasly Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Tasly Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 37,369.84 tCOâ‚‚e and total revenues of USD 1,164 millions. This translates into an emissions intensity of 32.09 tCOâ‚‚e per millions USD.a
Tasly Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers
How does Tasly Pharmaceutical Group's GHG emissions intensity compare to its peers?
In 2024, Tasly Pharmaceutical Group reported a Scope 1 emissions intensity of 32.09 tCOâ‚‚e per millions USD. Compared to the peer group median of 23.6, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does Tasly Pharmaceutical Group rank on GHG emissions intensity within its industry?
In 2024, Tasly Pharmaceutical Group ranked 16 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Tasly Pharmaceutical Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a